Intel Seeks Cancellation Of Dopant Concentration Patent In New Petition
ALEXANDRIA, Va. — In a Jan. 30 petition for inter partes review (IPR) filed with the Patent Trial and Appeal Board, Intel Corp. asserts five claims of a patent directed to...To view the full article, register now.
Already a subscriber? Click here to view full article